{"pmid":32303837,"title":"Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2.","text":["Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2.","J Neurol","Willis, M D","Robertson, N P","32303837"],"journal":"J Neurol","authors":["Willis, M D","Robertson, N P"],"date":"2020-04-19T11:00:00Z","year":2020,"_id":"32303837","week":"202016|Apr 13 - Apr 19","doi":"10.1007/s00415-020-09822-3","source":"PubMed","topics":["Prevention","Treatment"],"weight":1,"_version_":1664431720376565760,"score":8.233237,"similar":[{"pmid":32241953,"title":"Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic.","text":["Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic.","The emergence of novel Coronavirus 2019 (COVID-19)(1) and the subsequent pandemic present a unique challenge to Neurologists managing patients with multiple sclerosis (MS) and related neuroinflammatory disorders, such as neuromyelitis spectrum disorder (NMOSD).","Neurology","Brownlee, Wallace","Bourdette, Dennis","Broadley, Simon","Killestein, Joep","Ciccarelli, Olga","32241953"],"abstract":["The emergence of novel Coronavirus 2019 (COVID-19)(1) and the subsequent pandemic present a unique challenge to Neurologists managing patients with multiple sclerosis (MS) and related neuroinflammatory disorders, such as neuromyelitis spectrum disorder (NMOSD)."],"journal":"Neurology","authors":["Brownlee, Wallace","Bourdette, Dennis","Broadley, Simon","Killestein, Joep","Ciccarelli, Olga"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32241953","week":"202014|Mar 30 - Apr 05","doi":"10.1212/WNL.0000000000009507","source":"PubMed","topics":["Treatment","Prevention"],"weight":1,"_version_":1663352135743438848,"score":82.86554},{"pmid":32303856,"title":"Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic.","text":["Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic.","We propose a possible approach for the remote monitoring of infection risk in people with multiple sclerosis, especially those on immunosuppressant drugs, during COVID-19 pandemic. We developed a digital triage tool to be sent to patients to quickly identify people with high risk of COVID-19 infection. This tool will also limit unnecessary accesses to the MS centers reducing the risk of spreading the infection.","Neurol Sci","Bonavita, Simona","Tedeschi, Gioacchino","Atreja, Ashish","Lavorgna, Luigi","32303856"],"abstract":["We propose a possible approach for the remote monitoring of infection risk in people with multiple sclerosis, especially those on immunosuppressant drugs, during COVID-19 pandemic. We developed a digital triage tool to be sent to patients to quickly identify people with high risk of COVID-19 infection. This tool will also limit unnecessary accesses to the MS centers reducing the risk of spreading the infection."],"journal":"Neurol Sci","authors":["Bonavita, Simona","Tedeschi, Gioacchino","Atreja, Ashish","Lavorgna, Luigi"],"date":"2020-04-19T11:00:00Z","year":2020,"_id":"32303856","week":"202016|Apr 13 - Apr 19","doi":"10.1007/s10072-020-04391-9","keywords":["covid 19","digital health","digital triage","multiple sclerosis"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664431720496103426,"score":75.89849},{"pmid":32271605,"title":"Evaluation of the Level of Anxiety among Iranian Multiple Sclerosis Fellowships During the Outbreak of COVID-19.","text":["Evaluation of the Level of Anxiety among Iranian Multiple Sclerosis Fellowships During the Outbreak of COVID-19.","Arch Iran Med","Naser Moghadasi, Abdorreza","32271605"],"journal":"Arch Iran Med","authors":["Naser Moghadasi, Abdorreza"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32271605","week":"202015|Apr 06 - Apr 12","doi":"10.34172/aim.2020.13","source":"PubMed","locations":["Iranian"],"countries":["Iran, Islamic Republic of"],"countries_codes":["IRN|Iran, Islamic Republic of"],"weight":0,"_version_":1663620083117719552,"score":67.337425},{"pmid":32226285,"pmcid":"PMC7098030","title":"SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat.","text":["SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat.","An ongoing outbreak of pneumonia caused by a novel coronavirus, currently designated as the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), was reported recently. However, as SARS-CoV-2 is an emerging virus, we know little about it. In this review, we summarize the key events occurred during the early stage of SARS-CoV-2 outbreak, the basic characteristics of the pathogen, the signs and symptoms of the infected patients as well as the possible transmission pathways of the virus. Furthermore, we also review the current knowledge on the origin and evolution of the SARS-CoV-2. We highlight bats as the potential natural reservoir and pangolins as the possible intermediate host of the virus, but their roles are waiting for further investigation. Finally, the advances in the development of chemotherapeutic options are also briefly summarized.","Int J Biol Sci","Zheng, Jun","32226285"],"abstract":["An ongoing outbreak of pneumonia caused by a novel coronavirus, currently designated as the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), was reported recently. However, as SARS-CoV-2 is an emerging virus, we know little about it. In this review, we summarize the key events occurred during the early stage of SARS-CoV-2 outbreak, the basic characteristics of the pathogen, the signs and symptoms of the infected patients as well as the possible transmission pathways of the virus. Furthermore, we also review the current knowledge on the origin and evolution of the SARS-CoV-2. We highlight bats as the potential natural reservoir and pangolins as the possible intermediate host of the virus, but their roles are waiting for further investigation. Finally, the advances in the development of chemotherapeutic options are also briefly summarized."],"journal":"Int J Biol Sci","authors":["Zheng, Jun"],"date":"2020-04-01T11:00:00Z","year":2020,"_id":"32226285","week":"202014|Mar 30 - Apr 05","doi":"10.7150/ijbs.45053","keywords":["*COVID-19","*Coronavirus","*Novel coronavirus","*SARS-CoV-2","*pneumonia"],"source":"PubMed","topics":["Mechanism","Diagnosis","Transmission","Treatment"],"weight":1,"_version_":1663352135242219520,"score":48.747715},{"pmid":32103284,"pmcid":"PMC7079839","title":"Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists.","text":["Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists.","Intensive Care Med","Bouadma, Lila","Lescure, Francois-Xavier","Lucet, Jean-Christophe","Yazdanpanah, Yazdan","Timsit, Jean-Francois","32103284"],"journal":"Intensive Care Med","authors":["Bouadma, Lila","Lescure, Francois-Xavier","Lucet, Jean-Christophe","Yazdanpanah, Yazdan","Timsit, Jean-Francois"],"date":"2020-02-28T11:00:00Z","year":2020,"_id":"32103284","week":"20209|Feb 24 - Mar 01","doi":"10.1007/s00134-020-05967-x","source":"PubMed","topics":["Prevention","Diagnosis","Treatment"],"weight":1,"_version_":1663352134449496065,"score":48.353775}]}